APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neuroleptics

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Neuroleptics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025186 pages

Choose your research edition.

Industry ResearchNeuroleptics Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Neuroleptics Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Neuroleptics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neuroleptics Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Neuroleptics Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Neuroleptics market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Neuroleptics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Neuroleptics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Neuroleptics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Neuroleptics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Neuroleptics include Johnson & Johnson, Eli Lilly, Pfizer, GSK, Bristol-Myers Squibb, AstraZeneca and Allergan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Neuroleptics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Neuroleptics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Neuroleptics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Neuroleptics market size, projected growth trends, production technologies, key applications, and end-use industries.

Neuroleptics Segment by Company

Johnson & Johnson

Eli Lilly

Pfizer

GSK

Bristol-Myers Squibb

AstraZeneca

Allergan

Neuroleptics Segment by Type

First Generation

Second Generation

Third Generation

Neuroleptics Segment by Application

Bipolar Disorder

Schizophrenia

Unipolar Depression

Dementia

Others

Neuroleptics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neuroleptics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neuroleptics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neuroleptics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Neuroleptics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Neuroleptics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Neuroleptics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Neuroleptics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Neuroleptics Industry Trends Table 2. Neuroleptics Industry Drivers Table 3. Neuroleptics Industry Opportunities and Challenges Table 4. Neuroleptics Industry Restraints Table 5. Global Neuroleptics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Neuroleptics Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Neuroleptics Sales by Manufacturers (k tons) & (2021-2026) Table 8. Global Neuroleptics Sales Market Share by Manufacturers Table 9. Global Neuroleptics Average Sales Price (US$/ton) of Manufacturers (2021-2026) Table 10. Global Neuroleptics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Neuroleptics Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Neuroleptics Manufacturers, Product Type & Application Table 13. Global Neuroleptics Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Neuroleptics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of First Generation Table 17. Major Manufacturers of Second Generation Table 18. Major Manufacturers of Third Generation Table 19. Global Neuroleptics Sales by Type 2021 VS 2025 VS 2032 (k tons) Table 20. Global Neuroleptics Sales by Type (2021-2026) & (k tons) Table 21. Global Neuroleptics Sales by Type (2027-2032) & (k tons) Table 22. Global Neuroleptics Sales Market Share by Type (2021-2026) Table 23. Global Neuroleptics Sales Market Share by Type (2027-2032) Table 24. Global Neuroleptics Revenue by Type 2021 VS 2025 VS 2032 (k tons) Table 25. Global Neuroleptics Revenue by Type (2021-2026) & (k tons) Table 26. Global Neuroleptics Revenue by Type (2027-2032) & (k tons) Table 27. Global Neuroleptics Revenue Market Share by Type (2021-2026) Table 28. Global Neuroleptics Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Bipolar Disorder Table 30. Major Manufacturers of Schizophrenia Table 31. Major Manufacturers of Unipolar Depression Table 32. Major Manufacturers of Dementia Table 33. Major Manufacturers of Others Table 34. Global Neuroleptics Sales by Application 2021 VS 2025 VS 2032 (k tons) Table 35. Global Neuroleptics Sales by Application (2021-2026) & (k tons) Table 36. Global Neuroleptics Sales by Application (2027-2032) & (k tons) Table 37. Global Neuroleptics Sales Market Share by Application (2021-2026) Table 38. Global Neuroleptics Sales Market Share by Application (2027-2032) Table 39. Global Neuroleptics Revenue by Application 2021 VS 2025 VS 2032 (k tons) Table 40. Global Neuroleptics Revenue by Application (2021-2026) & (k tons) Table 41. Global Neuroleptics Revenue by Application (2027-2032) & (k tons) Table 42. Global Neuroleptics Revenue Market Share by Application (2021-2026) Table 43. Global Neuroleptics Revenue Market Share by Application (2027-2032) Table 44. Global Neuroleptics Sales by Region: 2021 VS 2025 VS 2032 (k tons) Table 45. Global Neuroleptics Sales by Region (2021-2026) & (k tons) Table 46. Global Neuroleptics Sales Market Share by Region (2021-2026) Table 47. Global Neuroleptics Sales Forecasted by Region (2027-2032) & (k tons) Table 48. Global Neuroleptics Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Neuroleptics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 50. North America Neuroleptics Sales by Country (2021-2026) & (k tons) Table 51. North America Neuroleptics Sales by Country (2027-2032) & (k tons) Table 52. Europe Neuroleptics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 53. Europe Neuroleptics Sales by Country (2021-2026) & (k tons) Table 54. Europe Neuroleptics Sales by Country (2027-2032) & (k tons) Table 55. Asia Pacific Neuroleptics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 56. Asia Pacific Neuroleptics Sales by Country (2021-2026) & (k tons) Table 57. Asia Pacific Neuroleptics Sales by Country (2027-2032) & (k tons) Table 58. South America, Middle East and Africa Neuroleptics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 59. South America, Middle East and Africa Neuroleptics Sales by Country (2021-2026) & (k tons) Table 60. South America, Middle East and Africa Neuroleptics Sales by Country (2027-2032) & (k tons) Table 61. Global Neuroleptics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Neuroleptics Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Neuroleptics Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Neuroleptics Revenue Market Share by Region (2021-2026) Table 65. Global Neuroleptics Revenue Market Share by Region (2027-2032) Table 66. Johnson & Johnson Company Information Table 67. Johnson & Johnson Business Overview Table 68. Johnson & Johnson Neuroleptics Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Johnson & Johnson Neuroleptics Product Portfolio Table 70. Johnson & Johnson Recent Development Table 71. Eli Lilly Company Information Table 72. Eli Lilly Business Overview Table 73. Eli Lilly Neuroleptics Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Eli Lilly Neuroleptics Product Portfolio Table 75. Eli Lilly Recent Development Table 76. Pfizer Company Information Table 77. Pfizer Business Overview Table 78. Pfizer Neuroleptics Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Pfizer Neuroleptics Product Portfolio Table 80. Pfizer Recent Development Table 81. GSK Company Information Table 82. GSK Business Overview Table 83. GSK Neuroleptics Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. GSK Neuroleptics Product Portfolio Table 85. GSK Recent Development Table 86. Bristol-Myers Squibb Company Information Table 87. Bristol-Myers Squibb Business Overview Table 88. Bristol-Myers Squibb Neuroleptics Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Bristol-Myers Squibb Neuroleptics Product Portfolio Table 90. Bristol-Myers Squibb Recent Development Table 91. AstraZeneca Company Information Table 92. AstraZeneca Business Overview Table 93. AstraZeneca Neuroleptics Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. AstraZeneca Neuroleptics Product Portfolio Table 95. AstraZeneca Recent Development Table 96. Allergan Company Information Table 97. Allergan Business Overview Table 98. Allergan Neuroleptics Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Allergan Neuroleptics Product Portfolio Table 100. Allergan Recent Development Table 101. Key Raw Materials Table 102. Raw Materials Key Suppliers Table 103. Neuroleptics Distributors List Table 104. Neuroleptics Customers List Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Neuroleptics Product Image Figure 2. Global Neuroleptics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neuroleptics Market Size (2021-2032) & (US$ Million) Figure 4. Global Neuroleptics Sales (2021-2032) & (k tons) Figure 5. Global Neuroleptics Average Price (US$/ton) & (2021-2032) Figure 6. Global Top 5 and 10 Neuroleptics Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. First Generation Image Figure 9. Second Generation Image Figure 10. Third Generation Image Figure 11. Global Neuroleptics Sales by Type (2021 VS 2025 VS 2032) & (k tons) Figure 12. Global Neuroleptics Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Neuroleptics Sales Market Share by Type (2021-2032) Figure 14. Global Neuroleptics Revenue by Type (2021 VS 2025 VS 2032) & (k tons) Figure 15. Global Neuroleptics Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Neuroleptics Revenue Market Share by Type (2021-2032) Figure 17. Bipolar Disorder Image Figure 18. Schizophrenia Image Figure 19. Unipolar Depression Image Figure 20. Dementia Image Figure 21. Others Image Figure 22. Global Neuroleptics Sales by Application (2021 VS 2025 VS 2032) & (k tons) Figure 23. Global Neuroleptics Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Neuroleptics Sales Market Share by Application (2021-2032) Figure 25. Global Neuroleptics Revenue by Application (2021 VS 2025 VS 2032) & (k tons) Figure 26. Global Neuroleptics Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Neuroleptics Revenue Market Share by Application (2021-2032) Figure 28. North America Neuroleptics Sales and Growth Rate (2021-2032) & (k tons) Figure 29. North America Neuroleptics Sales Market Share by Country (2021-2032) Figure 30. U.S. Neuroleptics Sales and Growth Rate (2021-2032) & (k tons) Figure 31. Canada Neuroleptics Sales and Growth Rate (2021-2032) & (k tons) Figure 32. Mexico Neuroleptics Sales and Growth Rate (2021-2032) & (k tons) Figure 33. Europe Neuroleptics Sales and Growth Rate (2021-2032) & (k tons) Figure 34. Europe Neuroleptics Sales Market Share by Country (2021-2032) Figure 35. Germany Neuroleptics Sales and Growth Rate (2021-2032) & (k tons) Figure 36. France Neuroleptics Sales and Growth Rate (2021-2032) & (k tons) Figure 37. U.K. Neuroleptics Sales and Growth Rate (2021-2032) & (k tons) Figure 38. Italy Neuroleptics Sales and Growth Rate (2021-2032) & (k tons) Figure 39. Netherlands Neuroleptics Sales and Growth Rate (2021-2032) & (k tons) Figure 40. Asia Pacific Neuroleptics Sales and Growth Rate (2021-2032) & (k tons) Figure 41. Asia Pacific Neuroleptics Sales Market Share by Country (2021-2032) Figure 42. China Neuroleptics Sales and Growth Rate (2021-2032) & (k tons) Figure 43. Japan Neuroleptics Sales and Growth Rate (2021-2032) & (k tons) Figure 44. South Korea Neuroleptics Sales and Growth Rate (2021-2032) & (k tons) Figure 45. Southeast Asia Neuroleptics Sales and Growth Rate (2021-2032) & (k tons) Figure 46. India Neuroleptics Sales and Growth Rate (2021-2032) & (k tons) Figure 47. Australia Neuroleptics Sales and Growth Rate (2021-2032) & (k tons) Figure 48. South America, Middle East and Africa Neuroleptics Sales and Growth Rate (2021-2032) & (k tons) Figure 49. South America, Middle East and Africa Neuroleptics Sales Market Share by Country (2021-2032) Figure 50. Brazil Neuroleptics Sales and Growth Rate (2021-2032) & (k tons) Figure 51. South Africa Neuroleptics Sales and Growth Rate (2021-2032) & (k tons) Figure 52. Saudi Arabia Neuroleptics Sales and Growth Rate (2021-2032) & (k tons) Figure 53. Turkey Neuroleptics Sales and Growth Rate (2021-2032) & (k tons) Figure 54. Argentina Neuroleptics Sales and Growth Rate (2021-2032) & (k tons) Figure 55. UAE Neuroleptics Sales and Growth Rate (2021-2032) & (k tons) Figure 56. Egypt Neuroleptics Sales and Growth Rate (2021-2032) & (k tons) Figure 57. Chile Neuroleptics Sales and Growth Rate (2021-2032) & (k tons) Figure 58. Global Neuroleptics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Neuroleptics Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Neuroleptics Revenue (2021-2032) & (US$ Million) Figure 61. North America Neuroleptics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Neuroleptics Revenue (2021-2032) & (US$ Million) Figure 63. Europe Neuroleptics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Neuroleptics Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Neuroleptics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Neuroleptics Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Neuroleptics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Neuroleptics Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Neuroleptics Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • First Generation
  • Second Generation
  • Third Generation
Applications
  • Bipolar Disorder
  • Schizophrenia
  • Unipolar Depression
  • Dementia
  • Others
Companies covered
  • Johnson & Johnson
  • Eli Lilly
  • Pfizer
  • GSK
  • Bristol-Myers Squibb
  • AstraZeneca
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Neuroleptics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Neuroleptics Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Neuroleptics Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Neuroleptics Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Neuroleptics Market Dynamics
  1. 2.1 Neuroleptics Industry Trends
  2. 2.2 Neuroleptics Industry Drivers
  3. 2.3 Neuroleptics Industry Opportunities and Challenges
  4. 2.4 Neuroleptics Industry Restraints
3 Neuroleptics Market by Manufacturers
  1. 3.1 Global Neuroleptics Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Neuroleptics Sales by Manufacturers (2021-2026)
  3. 3.3 Global Neuroleptics Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Neuroleptics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Neuroleptics Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Neuroleptics Manufacturers, Product Type & Application
  7. 3.7 Global Neuroleptics Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Neuroleptics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Neuroleptics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Neuroleptics Tier 1, Tier 2, and Tier 3
4 Neuroleptics Market by Type
  1. 4.1 Neuroleptics Type Introduction
  2. 4.1.1 First Generation
  3. 4.1.2 Second Generation
  4. 4.1.3 Third Generation
  5. 4.2 Global Neuroleptics Sales by Type
  6. 4.2.1 Global Neuroleptics Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Neuroleptics Sales by Type (2021-2032)
  8. 4.2.3 Global Neuroleptics Sales Market Share by Type (2021-2032)
  9. 4.3 Global Neuroleptics Revenue by Type
  10. 4.3.1 Global Neuroleptics Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Neuroleptics Revenue by Type (2021-2032)
  12. 4.3.3 Global Neuroleptics Revenue Market Share by Type (2021-2032)
5 Neuroleptics Market by Application
  1. 5.1 Neuroleptics Application Introduction
  2. 5.1.1 Bipolar Disorder
  3. 5.1.2 Schizophrenia
  4. 5.1.3 Unipolar Depression
  5. 5.1.4 Dementia
  6. 5.1.5 Others
  7. 5.2 Global Neuroleptics Sales by Application
  8. 5.2.1 Global Neuroleptics Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Neuroleptics Sales by Application (2021-2032)
  10. 5.2.3 Global Neuroleptics Sales Market Share by Application (2021-2032)
  11. 5.3 Global Neuroleptics Revenue by Application
  12. 5.3.1 Global Neuroleptics Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Neuroleptics Revenue by Application (2021-2032)
  14. 5.3.3 Global Neuroleptics Revenue Market Share by Application (2021-2032)
6 Global Neuroleptics Sales by Region
  1. 6.1 Global Neuroleptics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Neuroleptics Sales by Region (2021-2032)
  3. 6.2.1 Global Neuroleptics Sales by Region (2021-2026)
  4. 6.2.2 Global Neuroleptics Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Neuroleptics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Neuroleptics Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Neuroleptics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Neuroleptics Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Neuroleptics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Neuroleptics Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Neuroleptics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Neuroleptics Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Neuroleptics Revenue by Region
  1. 7.1 Global Neuroleptics Revenue by Region
  2. 7.1.1 Global Neuroleptics Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Neuroleptics Revenue by Region (2021-2026)
  4. 7.1.3 Global Neuroleptics Revenue by Region (2027-2032)
  5. 7.1.4 Global Neuroleptics Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Neuroleptics Revenue (2021-2032)
  8. 7.2.2 North America Neuroleptics Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Neuroleptics Revenue (2021-2032)
  11. 7.3.2 Europe Neuroleptics Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Neuroleptics Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Neuroleptics Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Neuroleptics Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Neuroleptics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson Neuroleptics Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson Neuroleptics Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Eli Lilly
  8. 8.2.1 Eli Lilly Company Information
  9. 8.2.2 Eli Lilly Business Overview
  10. 8.2.3 Eli Lilly Neuroleptics Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Eli Lilly Neuroleptics Product Portfolio
  12. 8.2.5 Eli Lilly Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Neuroleptics Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Neuroleptics Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 GSK
  20. 8.4.1 GSK Company Information
  21. 8.4.2 GSK Business Overview
  22. 8.4.3 GSK Neuroleptics Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GSK Neuroleptics Product Portfolio
  24. 8.4.5 GSK Recent Developments
  25. 8.5 Bristol-Myers Squibb
  26. 8.5.1 Bristol-Myers Squibb Company Information
  27. 8.5.2 Bristol-Myers Squibb Business Overview
  28. 8.5.3 Bristol-Myers Squibb Neuroleptics Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bristol-Myers Squibb Neuroleptics Product Portfolio
  30. 8.5.5 Bristol-Myers Squibb Recent Developments
  31. 8.6 AstraZeneca
  32. 8.6.1 AstraZeneca Company Information
  33. 8.6.2 AstraZeneca Business Overview
  34. 8.6.3 AstraZeneca Neuroleptics Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 AstraZeneca Neuroleptics Product Portfolio
  36. 8.6.5 AstraZeneca Recent Developments
  37. 8.7 Allergan
  38. 8.7.1 Allergan Company Information
  39. 8.7.2 Allergan Business Overview
  40. 8.7.3 Allergan Neuroleptics Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Allergan Neuroleptics Product Portfolio
  42. 8.7.5 Allergan Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Neuroleptics Value Chain Analysis
  2. 9.1.1 Neuroleptics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Neuroleptics Production Mode & Process
  6. 9.2 Neuroleptics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Neuroleptics Distributors
  9. 9.2.3 Neuroleptics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst